LEO Pharma is a global pharmaceutical company dedicated to developing treatments and solutions that deliver value to patients and societies all around the world.
CancerClot™ is wholly funded and developed by LEO Pharma. Founded in 1908, LEO Pharma is a global pharmaceutical company dedicated to helping people achieve healthy skin. As an independent, research-based pharmaceutical company, LEO Pharma develops, manufactures and markets pharmaceutical treatments to dermatologic and thrombotic patients in more than 100 countries globally.
At LEO Pharma, we are dedicated to developing treatments and solutions that deliver unique value to patients and societies all around the world. Our goal is to improve the quality of life for people living with cancer associated thrombosis.
In order to help people achieve better treatment outcomes and meet their needs, we listen to people living with cancer associated thrombosis. We know that it’s not just about the disease, but about the people living with the condition and the impact on their everyday lives. We believe that there is more to medical care than appointments, treatments and solutions.
By actively listening to people, we understand the emotional and psychological challenges of living with cancer associated thrombosis. Combined with our medical expertise and scientific knowledge, we have developed CancerClot™, a free and confidential support service designed to provide personalised information, value and support during all stages of a disease journey. The aim of our initiative is to empower people to address their concerns and take control of their condition.